In this issue:<br> • Radiant Research Acquires Asthma, Allergy Site in San Diego <br> • FDA Lifts Research Suspension at University of Colorado <br> • Quarterly Reports <br> • Premier Research Completes Sale of CRO to SCP <br> • PPD GenuPro Retains Rights to Compound <br> • The CenterWatch Index <br> • Personnel <br> • Industry Briefs <br> • Drug Pipeline News <br> • Trial Results <br>